Enliven Therapeutics, Inc. ($ELVN)
Collins Helen Louise โ CHIEF MEDICAL OFFICER
Shares
40,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
Mar 12, 2026
EPS:Est: -0.42
Transaction Details
| Insider | Collins Helen Louise |
|---|---|
| Title | CHIEF MEDICAL OFFICER |
| Transaction Date | Mar 25, 2026 |
| Expiration Date | Jun 17, 2031 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 27, 2026 |
| Shares Purchased | 40,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 136,268 |
| Derivative | Derivative |
| Accession Number | 0001701247-26-000005 |
| Document | View SEC Filing |